Christopher Langmead

Company: Amgen
Job title: Director, Digital Biologics Discovery
Seminars:
Panel Discussion: Using Deep & Machine Learning Methods to Develop & Optimize Therapeutic Anti-bodies 9:30 am
Revealing the pillars for ML-based optimization of therapeutic antibodies Outlining recent progress in the application of ML methods for antibody optimization Comparing organizational strategies for developing optimal therapeutic antibodiesRead more
day: Day Two
Addressing the Design & Engineering of Multi-specific, Multifunctional Antibodies to Advance the Constructs in-Vivo and into the Clinic 4:30 pm
Discussing advances in the development of multifunctional antibodies with favourable stability, specificity, and pharmacokinetic properties Exploring Emerging computational methods for enhancing the next generation of multi-specific antibodies Leveraging current know-how by translating learnings from IgG1 design to multispecificsRead more
day: Day One